Cite
HARVARD Citation
Pappas, P. et al. (n.d.). 120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis. Open forum infectious diseases. p. S72. [Online].